Profluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture.
Philly police and federal authorities used wiretaps, cameras, and confidential informants to target dealers on Weymouth ...
Explore the advantages of virtual screening in drug discovery, offering rapid evaluation and cost savings over traditional ...
From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...
BOSTON, November 24, 2025--1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today ...
Gain leadership and innovation insights from CEO of the Year finalist at 2025 CPHI Pharma Awards, Mahler Hanns-Christian, who ...
“The best ideas in drug discovery were often blocked not by biology, but by synthesis,” Boiko told TechCrunch. Synthesis is ...
The Allen Institute for AI (Ai2) unveiled Olmo 3, a new generation of open language models that it says outperforms rivals ...
The UK drug development process is evolving. Find out how government efforts are reducing clinical trial timelines for new ...
Neural tissue engineering aims to mimic the brain's complex environment, the extracellular matrix, which supports nerve cell ...
Since Zahid Salman took over as CEO in 2018 and instilled a new mindset, the company’s annual revenues and social impact has ...
For the first time, scientists have grown functional, brain-like tissue without using any animal-derived materials or added ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback